Outbreak of COVID-19 underscores Growth for Respiratory Syncytial Virus Diagnostics Market

High rate of incidence of respiratory syncytial virus, especially among the elderly and infants is a significant growth factor for respiratory syncytial virus diagnostics market. Respiratory syncytial virus causes respiratory infections such as bronchiolitis and pneumonia, with recovery mostly in a week or two. However, respiratory syncytial virus can sometimes be fatal, which necessitates early diagnosis. According to statistics, more than 99 percent of respiratory syncytial virus deaths are among children below the age of five years.

Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6519

The respiratory syncytial diagnostics market is highly fragmented with the presence of large number of local and international players. Savvy players are focusing on R&D to speed up the diagnosis of respiratory syncytial virus. Mergers and acquisitions, partnerships is also what keen players in the respiratory syncytial virus market are striving for. Prominent names in the respiratory syncytial virus market include Hoffmann La Roche Limited, Coris BioConcept, Novartis Diagnostics, Abbott Laboratories, Fast-track diagnostics, Quidel Corporation, Quest Diagnostics, Alere Inc., and Diasorin SPA.

Risk of Co-infection for Covid-19 Patient triggers Demand

The outbreak of COVID-19 is indirectly aiding the respiratory syncytial virus diagnosis market. The outbreak of the pandemic has led to the dire need for speedy screening devices. Research communities and scientists worldwide are striving to develop new technologies to speed up screening of COVID-19. Minor changes in screening devices for respiratory syncytial virus makes them suitable to be used for COVID-19 screening, thereby stoking demand for respiratory syncytial virus diagnosis devices.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6519

Also, according to another finding, one in five COVID-19 patient is co-infected with another respiratory virus. Among them, individuals with symptoms of respiratory syncytial virus may go for testing of the virus. This, therefore boosts the respiratory syncytial virus diagnostics market. Furthermore, due to the maximum number of COVID-19 cases in the U.S., demand for the respiratory syncytial virus diagnostic devices is receiving a boost in North America.

Author: Rohit Bhisey

As Head of Marketing at TMR Research, Rohit brings to the table over a decade of experience in market research and Internet marketing. His dedication, perseverance, and passion for perfection have enabled him to achieve immense success in his field. Rohit is an expert at formulating new business plans and strategies to help boost web traffic. His interests lie in writing news articles on technology,healthcare and business.

Leave a Reply